Helping The others Realize The Advantages Of Antidepressant agent 5
MI-CP151 was a stage 1b randomised, double-blind, placebo managed, dose-escalation, multicentre study To guage numerous intravenous doses of sifalimumab, in Grownup patients with dermatomyositis or polymyositis (NCT00533091). Most important demo goals had been To guage the safety and tolerability of sifalimumab in dermatomyositis or polymyositis pe